Suramin hexasodium salt extract, ACS – CAS 129-46-4
Price f.o.b. for gr.1
€ 1150.00
Additional information
| Weight | 1 g |
|---|---|
| product name | Suramin hexasodium salt extract, ACS |
| synonyms | (-)-Shikimic acid Suramin from illicium extract , |
| product origin | 100% made in European Union *(according to USP, EUP, ECHA-REACH) |
| purity grade | >99.99% (raw virgin matter, ultra-pure, sterilized) |
| use | lab. / tech. / bio-research / supplement |
| product code | EA61707 |
| C.A.S. number | 129-46-4 |
| MDL | MFCD00210217 |
| EINECS | 204-949-3 |
| formula molecular | C51H34N6Na6O23S6 |
| alternative formula | C7H10O5 |
| formula weight | 1429.16 |
| assay (HPLC) | >99.99% to <101.5% |
| sensitivity & storage | store in cool place; keep container tightly closed in a dry and well-ventilated place (5 °C to 25°C) |
| solubility | in water and saline (turbidity) <15% (H2O >10 mg/ml); sparingly soluble in 95% bethanol |
| appearance (color) | white to pale cream |
| form | powder |
| observation | This raw matter observed for antiparasitic drug , which blocks endothelial cell proliferation and increases tyrosine phosphorylation of many signalling proteins, |
| note (1) | store in cool place ; keep container tightly closed in a dry and well-ventilated place ; |
| note (2) | this product is for research use only, is not to be used for therapeutic ; not intended for animal or human or diagnostic or therapeutic use , and cannot be sold to patients. |
| note (3) | described price of the product is NOT NEGOTIABLE , already around 25% lower than the official price of the International Chemical Stock Exchange / ICIS . * Possible additional discount for large quantity orders . |
| shelf life | 2 (two) years from production date (sealed package) , * shipped in ambient temperature ( note 1) |
| packaging / transport | special for chemical transport (according to IATA / ADR / ECHA-REACH rules / int.l laws) . |
| certifications | C.O.A., MSDS, GMP, API, USP, EUP, ECHA-REACH, ORIGIN, etc… |
Reviews
There are no reviews yet.